← Open Payments lookup

EMILY ADAMS: Open Payments

NPI 1710060033 · GREENCASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$899 in 49 payments from 12 companies in 2025. Trend: 2023 $672 · 2024 $948 · 2025 $899

Food & beverage: $899
CompanyPaymentsAmount
ABBVIE INC.10$179
Axsome Therapeutics, Inc.8$164
Amgen Inc.9$138
Novo Nordisk Inc5$90
AstraZeneca Pharmaceuticals LP3$55
Lilly USA, LLC3$54
GlaxoSmithKline, LLC.3$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Corium, LLC2$42
Bayer Healthcare Pharmaceuticals Inc.2$42

Products named: Auvelity, OTEZLA, QULIPTA, VRAYLAR, Wegovy, CAPLYTA, Azstarys, Kerendia.

Industry payments across IN — which companies pay providers there.